Inverted perovskite solar cell breaks 25% efficiency record
Northwestern University researchers have raised the standards again for perovskite solar cells with a new development that helped the emerging technology hit new…
Browsing Tag
cell
Libtayo® (cemiplimab) Neoadjuvant Treatment Demonstrates Encouraging Event-Free Survival in Patients…
89% estimated event-free survival at one year among patients with stage II to IV resectable CSCC who received Libtayo prior to surgery in a Phase 2 trial No disease recurrence among the 51% of patients who experienced a pathologic…
Researchers construct first ‘multiome’ atlas of cell development in the human cerebral…
A team of researchers from the Icahn School of Medicine at Mount Sinai and Yale University School of Medicine has created the first "multiome" atlas of brain cell development in the human cerebral cortex across six broad developmental time…
Sickle Cell Disease Treatment Market Size to Surpass USD 8.75 Billion by 2029, exhibiting a CAGR of…
Pune, India, Oct. 05, 2023 (GLOBE NEWSWIRE) -- According to Fortune Business Insights, the global Sickle Cell Disease Treatment Market Size was valued at USD 1.73 billion in 2021 and is projected to grow from USD 2.25 billion in 2022 to…
Single Cell Protein Market Revenue to Cross USD 18 billion by 2031, Rising at a 9% CAGR: TMR Report
Wilmington, Delaware, United States, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The single cell protein market was estimated to have acquired US$ 5.1 billion in 2020. It is anticipated to register a 9% CAGR…
Sickle cell disease can be deadly, and the persistent health inequities facing Black Americans…
The pain from a heart attack is so bad that – if you can imagine – it can feel like an elephant sitting on you. Patients with sickle cell disease, a genetic condition affecting the red blood cells, report that this kind of pain begins…
BioLineRx stem cell drug for myeloma patients wins FDA nod
Israeli commercial stage biopharmaceutical company BioLineRx Ltd. (Nasdaq: BLRX; TASE: BLRX) today announced that the US Food and Drug Administration (FDA) has approved APHEXDA (motixafortide) in combination with…
Expanding the impact of CAR T cell therapy: An immunotherapy strategy against all blood cancers
A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, which is currently approved for five subtypes of blood cancer. Scientists in the Perelman School of Medicine at the University of…
Unlocking the secrets of cell antennas
The non-specific lethal (NSL) complex is a chromatin-associated factor that has been shown to regulate the expression of thousands of genes in both fruit flies and mammals. Abrogation of the NSL genes leads to the death of the organism, and…
Team identifies key driver of cancer cell death pathway that activates immune cells
Scientists have identified a protein that plays a pivotal role in the action of several emerging cancer therapies. The researchers say the discovery will likely aid efforts to fine-tune the use of immunotherapies against several challenging…